XML 53 R43.htm IDEA: XBRL DOCUMENT v3.22.2.2
Fresh-Start Accounting - Reorganization Adjustments (Details) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 6 Months Ended 9 Months Ended
Jun. 16, 2022
Sep. 30, 2022
Jun. 16, 2022
Jun. 16, 2022
Sep. 24, 2021
Jul. 01, 2022
Apr. 01, 2022
Dec. 31, 2021
Jun. 25, 2021
Mar. 26, 2021
Dec. 25, 2020
Reorganization, Chapter 11 [Line Items]                      
Cash and cash equivalents $ 297.9 $ 391.2 $ 297.9 $ 297.9 $ 1,322.6     $ 1,345.0      
Debt Instrument, Face Amount   3,583.6                  
Medicaid lawsuit liability 260.0 16.5 260.0 260.0       0.0      
Acthar Gel-Related Settlement, Non-current   69.2           0.0      
Opioid-Related Settlement, Emergence Payment 447.4   447.4 447.4              
Opioid-Related Settlement, Gross Amount of Deferred Payment 1,275.0   1,275.0 1,275.0              
Opioid-Related Litigation Settlement liability, Current   200.0           0.0      
Opioid-Related Litigation Settlement liability   342.8           0.0      
Liabilities subject to compromise   $ 0.0           $ 6,397.7      
Stock Issued During Period, Value, New Issues     2,189.7                
Adjustments to Additional Paid in Capital, Warrant Issued     13.9                
Ordinary shares, shares issued (in shares)   0                  
Ordinary shares, par value (in usd per share)               $ 0.20      
Stockholders' Equity Attributable to Parent $ 2,203.6 $ 1,849.1 $ 2,203.6 $ 2,203.6 513.4 $ 2,138.2 $ 195.0 $ 313.4 $ 776.0 $ 878.9 $ 1,019.2
Class of Warrant or Right, Exercise Price of Warrants or Rights $ 103.40   $ 103.40 $ 103.40              
Adjustments to Retained Deficit, Prepaid Success Fee $ (10.9)   $ (10.9) $ (10.9)              
Cancellation of Predecessor equity     (0.5)                
Ordinary Shares                      
Reorganization, Chapter 11 [Line Items]                      
Stock Issued During Period, Value, New Issues     0.1                
Stockholders' Equity Attributable to Parent 0.1 0.1 0.1 0.1 18.9 $ 0.1 $ 18.9 18.9 $ 18.9 $ 18.8 $ 18.8
Cancellation of Predecessor equity     (18.9)                
StrataGraft PRV                      
Reorganization, Chapter 11 [Line Items]                      
Other Indefinite-lived Intangible Assets 100.0   100.0 100.0              
Long-term Debt                      
Reorganization, Chapter 11 [Line Items]                      
Liabilities subject to compromise   0.0           $ 3,750.8      
Opioid Claimant Trust [Member]                      
Reorganization, Chapter 11 [Line Items]                      
Opioid-Related Settlement 1,725.0   1,725.0 1,725.0              
Receivables Financing Facility                      
Reorganization, Chapter 11 [Line Items]                      
Debt Instrument, Face Amount 200.0   200.0 200.0              
2017 Replacement Term Loan                      
Reorganization, Chapter 11 [Line Items]                      
Debt Instrument, Face Amount 1,392.9 1,382.8 1,392.9 1,392.9              
2018 Replacement Term Loan                      
Reorganization, Chapter 11 [Line Items]                      
Debt Instrument, Face Amount 369.7 367.1 369.7 369.7              
10.00% Second Lien Senior Notes                      
Reorganization, Chapter 11 [Line Items]                      
Debt Instrument, Face Amount 322.9 321.9 322.9 322.9              
Ten Point Zero Percent Second Lien Notes due 2029                      
Reorganization, Chapter 11 [Line Items]                      
Debt Instrument, Face Amount 375.0 366.8 375.0 375.0              
10.00% First Lien Senior Notes                      
Reorganization, Chapter 11 [Line Items]                      
Debt Instrument, Face Amount 495.0 495.0 495.0 495.0              
Eleven Point Five Percent First Lien Senior Secured Notes                      
Reorganization, Chapter 11 [Line Items]                      
Debt Instrument, Face Amount   650.0                  
Reorganization, Chapter 11, Fresh-Start Adjustment                      
Reorganization, Chapter 11 [Line Items]                      
Cash and cash equivalents 0.0   0.0 0.0              
Medicaid lawsuit liability 0.0   0.0 0.0              
Acthar Gel-Related Settlement, Non-current 0.0   0.0 0.0              
Opioid-Related Litigation Settlement liability, Current 0.0   0.0 0.0              
Opioid-Related Litigation Settlement liability 0.0   0.0 0.0              
Liabilities subject to compromise 0.0   0.0 0.0              
Stockholders' Equity Attributable to Parent (772.5)   (772.5) (772.5)              
Fresh-Start Adjustment, Prepaid Income Taxes 54.0   54.0 54.0              
Fresh-Start Adjustment, Spare Parts 3.9   3.9 3.9              
Fresh-Start Adjustments, Debt Issuance Costs 1.1   1.1 1.1              
Fresh-Start Adjustments, Income Tax Receivables $ 0.9   $ 0.9 $ 0.9              
Operating Lease, Weighted Average Discount Rate, Percent 11.83%   11.83% 11.83%              
Fresh-Start Adjustments, Right-of-Use Assets $ 1.6   $ 1.6 $ 1.6              
Fresh-Start Adjustments, Asbestos-Related Defense Costs, Current 6.1   6.1 6.1              
Fresh-Start Adjustments, Asbestos-Related Defense Costs, Non-Current 16.7   16.7 16.7              
Fresh-Start Adjustments, Lease Liabilities 6.9   6.9 6.9              
Fresh-Start Adjustments, Unamortized Debt Issuance Costs 5.1   5.1 5.1              
Fresh-Start Adjustments, Debt, Fair Value 23.5   23.5 23.5              
Adjustment to Retained Deficit, Inventory 851.8   851.8 851.8              
Adjustment to Retained Deficit, Property, Plant and Equipment (299.2)   (299.2) (299.2)              
Fresh-Start Adjustments, Intangible assets, net (2,014.4)   (2,014.4) (2,014.4)              
Adjustments to Retained Deficit, Current Asset Held for Sale 100.0   100.0 100.0              
Adjustment to Retained Deficit, Debt 18.4   18.4 18.4              
Adjustment to Retained Deficit, Other Assets and Liabilities (11.2)   (11.2) (11.2)              
Reorganization Items, net, Loss on Fresh-Start Adjustments (1,354.6) 0.0   1,354.6 0.0            
Fresh-Start Adjustments, Accumulated Other Comprehensive Income (9.9)   (9.9) (9.9)              
Fresh-Start Adjustments, Income Tax Benefit 582.1   582.1 582.1              
Fresh-Start Adjustment, Accumulated Retained Deficit (782.4)   (782.4) (782.4)              
Reorganization, Chapter 11, Fresh-Start Adjustment | Indemnification Receivable, Current                      
Reorganization, Chapter 11 [Line Items]                      
Change in Accounting Policy, Fresh-Start $ 4.3   $ 4.3 $ 4.3              
Reorganization, Chapter 11, Fresh-Start Adjustment | Finite-Lived Intangible Assets | Minimum                      
Reorganization, Chapter 11 [Line Items]                      
Discount Rate, Present Value of Future Cash Flows 13.00%   13.00% 13.00%              
Reorganization, Chapter 11, Fresh-Start Adjustment | Finite-Lived Intangible Assets | Maximum                      
Reorganization, Chapter 11 [Line Items]                      
Discount Rate, Present Value of Future Cash Flows 15.00%   15.00% 15.00%              
Reorganization, Chapter 11, Fresh-Start Adjustment | Indemnification Receivable, Non-Current                      
Reorganization, Chapter 11 [Line Items]                      
Change in Accounting Policy, Fresh-Start $ 16.0   $ 16.0 $ 16.0              
Reorganization, Chapter 11, Fresh-Start Adjustment | Accumulated Other Comprehensive Loss                      
Reorganization, Chapter 11 [Line Items]                      
Fresh-Start Adjustments, AOCI 8.1   8.1 8.1              
Fresh-Start Adjustments, AOCI, CTA 2.1   2.1 2.1              
Fresh-Start Adjustments, AOCI, Income Tax Effects 0.3   0.3 0.3              
Reorganization, Chapter 11, Predecessor, before Adjustment                      
Reorganization, Chapter 11 [Line Items]                      
Cash and cash equivalents 1,392.6   1,392.6 1,392.6              
Medicaid lawsuit liability 0.0   0.0 0.0              
Acthar Gel-Related Settlement, Non-current 0.0   0.0 0.0              
Opioid-Related Litigation Settlement liability, Current 0.0   0.0 0.0              
Opioid-Related Litigation Settlement liability 0.0   0.0 0.0              
Liabilities subject to compromise 6,402.7   6,402.7 6,402.7              
Stockholders' Equity Attributable to Parent $ 48.9   $ 48.9 $ 48.9              
Operating Lease, Weighted Average Discount Rate, Percent 8.85%   8.85% 8.85%              
Reorganization, Chapter 11, Plan Effect Adjustment                      
Reorganization, Chapter 11 [Line Items]                      
Proceeds from Debt, Net of Issuance Costs $ 637.0                    
Payment for Debt Extinguishment or Debt Prepayment Cost (900.0)                    
Upfront Payment of the Opioid-Related Litigation Settlement (447.4)                    
Upfront Payment of the Acthar Gel-Related Settlement (17.8)                    
Payment of Administrative, Priority and Trade Claims (26.2)                    
Payment of Professional Fees (43.5)                    
Payment to Fund Professional Fees Escrow (89.0)                    
Payment of General Unsecured Claims (135.0)                    
Payment of Noteholder Consent Fees (19.3)                    
Payments for Other Fees (53.5)                    
Reorganization Adjustments, Cashed Used (1,731.7)                    
Cash and cash equivalents (1,094.7)   $ (1,094.7) $ (1,094.7)              
Restricted Cash 89.0   89.0 89.0              
Prepaid Expense, Reorganization Adjustment 10.9                    
Payments for Cure and Standard, Administrative and Priority Payments 25.2   25.2 25.2              
Payables due to Professional Advisor Success Fees 14.6   14.6 14.6              
Medicaid lawsuit liability 16.5   16.5 16.5              
Acthar Gel-Related Settlement, Non-current 63.2   63.2 63.2              
Opioid-Related Litigation Settlement liability, Current 200.0   200.0 200.0              
Opioid-Related Litigation Settlement liability 304.3   304.3 304.3              
Contingent Consideration, Liability (41.8)   (41.8) (41.8)              
Liabilities subject to compromise (6,402.7)   (6,402.7) (6,402.7)              
Liabilities, Reinstated (59.8)   (59.8) (59.8)              
Stock Issued During Period, Value, New Issues (2,189.7)                    
Adjustments to Additional Paid in Capital, Warrant Issued 13.9                    
Issuance of Takeback 2L Notes (190.2)   (190.2) (190.2)              
Cash payments to settle amounts per the Plan (601.3)   (601.3) (601.3)              
Total consideration provided to settle amounts per the Plan (5,399.2)   $ (5,399.2) (5,399.2)              
Gain on settlement of liabilities subject to compromise $ 943.7 $ 0.0   $ (943.7) $ 0.0            
Ordinary shares, shares issued (in shares) 13,170,932 13,170,932 13,170,932 13,170,932              
Ordinary shares, par value (in usd per share) $ 0.01   $ 0.01 $ 0.01              
Additional Paid in Capital, Common Stock $ 2,189.6   $ 2,189.6 $ 2,189.6              
Stockholders' Equity Attributable to Parent $ 2,927.2   $ 2,927.2 $ 2,927.2              
Share Price $ 18.50   $ 18.50 $ 18.50              
Volatility, Black Scholes Model, Warrants 62.28%   62.28% 62.28%              
Risk-Free Interest Rate, Black Scholes Model, Warrants 3.34%   3.34% 3.34%              
Adjustment to Retained Deficit, Professional, Success and Exit Fees $ (91.6)   $ (91.6) $ (91.6)              
Adjustments to Retained Deficit, Prepaid Insurance (9.2)   (9.2) (9.2)              
Adjustment to Retained Deficit, Severance Accrual (5.7)   (5.7) (5.7)              
Adjustment to Retained Deficit, Income Tax Expense on Plan Adjustments (102.7)   (102.7) (102.7)              
Cancellation of Predecessor equity 4,002.3                    
Reorganization Adjustments to Retained Deficit 4,725.9   4,725.9 4,725.9              
Other Assets, Reorganization Adjustment 6.5                    
Reorganization, Chapter 11, Plan Effect Adjustment | Ordinary Shares                      
Reorganization, Chapter 11 [Line Items]                      
Stock Issued During Period, Value, New Issues 0.1                    
Reorganization, Chapter 11, Plan Effect Adjustment | StrataGraft PRV | General Unsecured Claims Trust                      
Reorganization, Chapter 11 [Line Items]                      
Contingent Consideration, Liability 35.0   35.0 35.0              
Reorganization, Chapter 11, Plan Effect Adjustment | StrataGraft CVR                      
Reorganization, Chapter 11 [Line Items]                      
Fair value of contingent liability 6.8   6.8 6.8              
Reorganization, Chapter 11, Plan Effect Adjustment | Accrued and other current liabilities                      
Reorganization, Chapter 11 [Line Items]                      
Restructuring Reserve 5.7   5.7 5.7              
Reinstatement of various successor obligations from LSTC 15.4   15.4 15.4              
Success fees for professionals 29.7   29.7 29.7              
Accrued and Other Current Liabilities, Reorganization Adjustment 50.8   50.8 50.8              
Reorganization, Chapter 11, Plan Effect Adjustment | Other Noncurrent Liabilities                      
Reorganization, Chapter 11 [Line Items]                      
Asbestos-related defense cost accrual 16.8   16.8 16.8              
Reorganization, Chapter 11, Plan Effect Adjustment | Accounts Payable                      
Reorganization, Chapter 11 [Line Items]                      
Liabilities subject to compromise 17.7   17.7 17.7              
Liabilities, Reinstated (0.1)   (0.1) (0.1)              
Reorganization, Chapter 11, Plan Effect Adjustment | Interest Payable, Current                      
Reorganization, Chapter 11 [Line Items]                      
Liabilities subject to compromise 35.2   35.2 35.2              
Reorganization, Chapter 11, Plan Effect Adjustment | Long-term Debt                      
Reorganization, Chapter 11 [Line Items]                      
Liabilities subject to compromise 3,746.2   3,746.2 3,746.2              
Liabilities, Reinstated (1,778.3)   (1,778.3) (1,778.3)              
Reorganization, Chapter 11, Plan Effect Adjustment | Accrued Environmental Loss Contingencies                      
Reorganization, Chapter 11 [Line Items]                      
Liabilities subject to compromise 67.2   67.2 67.2              
Reorganization, Chapter 11, Plan Effect Adjustment | Acthar Gel-Related Settlement                      
Reorganization, Chapter 11 [Line Items]                      
Liabilities subject to compromise 630.0   630.0 630.0              
Liabilities, Reinstated (79.7)   (79.7) (79.7)              
Reorganization, Chapter 11, Plan Effect Adjustment | Opioid-related litigation settlement liability                      
Reorganization, Chapter 11 [Line Items]                      
Liabilities subject to compromise 1,722.4   1,722.4 1,722.4              
Liabilities, Reinstated (504.3)   (504.3) (504.3)              
Reorganization, Chapter 11, Plan Effect Adjustment | Other current and non-current liabilities                      
Reorganization, Chapter 11 [Line Items]                      
Liabilities subject to compromise 151.6   151.6 151.6              
Liabilities, Reinstated (27.3)   (27.3) (27.3)              
Reorganization, Chapter 11, Plan Effect Adjustment | Liability, Defined Benefit Plan, Noncurrent                      
Reorganization, Chapter 11 [Line Items]                      
Liabilities subject to compromise 32.4   32.4 32.4              
Liabilities, Reinstated (32.4)   (32.4) (32.4)              
Reorganization, Chapter 11, Plan Effect Adjustment | Medicaid Lawsuit [Member]                      
Reorganization, Chapter 11 [Line Items]                      
Acthar Gel-Related Settlement, Emergence Payment, net of Interest 17.8   17.8 17.8              
Acthar Gel-Related Settlement, Gross Amount of Deferred Payments 245.0   245.0 245.0              
Reorganization, Chapter 11, Plan Effect Adjustment | Opioid Claimant Trust [Member]                      
Reorganization, Chapter 11 [Line Items]                      
Opioid-Related Settlement $ 1,725.0   $ 1,725.0 $ 1,725.0              
Reorganization, Chapter 11, Plan Effect Adjustment | Acthar Gel-Related Settlement                      
Reorganization, Chapter 11 [Line Items]                      
Discount Rate, Present Value of Future Cash Flows 27.80%   27.80% 27.80%              
Reorganization, Chapter 11, Plan Effect Adjustment | Opioid-related litigation settlement liability                      
Reorganization, Chapter 11 [Line Items]                      
Discount Rate, Present Value of Future Cash Flows 27.80%   27.80% 27.80%              
Reorganization, Chapter 11, Plan Effect Adjustment | Receivables Financing Facility                      
Reorganization, Chapter 11 [Line Items]                      
Payments of Debt Issuance Costs $ 2.6                    
Reorganization, Chapter 11, Plan Effect Adjustment | 2017 Replacement Term Loan                      
Reorganization, Chapter 11 [Line Items]                      
Debt Instrument, Face Amount 1,392.9   $ 1,392.9 $ 1,392.9              
Reorganization Plan Adjustment (169.4)   (169.4) (169.4)              
Reorganization, Chapter 11, Plan Effect Adjustment | 2018 Replacement Term Loan                      
Reorganization, Chapter 11 [Line Items]                      
Debt Instrument, Face Amount 369.7   369.7 369.7              
Reorganization Plan Adjustment (42.2)   (42.2) (42.2)              
Reorganization, Chapter 11, Plan Effect Adjustment | 2017 and 2018 Replacement Term Loan                      
Reorganization, Chapter 11 [Line Items]                      
Debt, Current 34.7   34.7 34.7              
Reorganization, Chapter 11, Plan Effect Adjustment | 10.00% Second Lien Senior Notes                      
Reorganization, Chapter 11 [Line Items]                      
Reorganization Plan Adjustment (95.7)   (95.7) (95.7)              
Reorganization, Chapter 11, Plan Effect Adjustment | Ten Point Zero Percent Second Lien Notes due 2029                      
Reorganization, Chapter 11 [Line Items]                      
Debt Instrument, Face Amount 375.0   375.0 375.0              
Reorganization Plan Adjustment (184.8)   (184.8) (184.8)              
Reorganization, Chapter 11, Plan Effect Adjustment | 10.00% First Lien Senior Notes                      
Reorganization, Chapter 11 [Line Items]                      
Debt Issuance Costs, Gross 5.1   5.1 5.1              
Reorganization, Chapter 11, Plan Effect Adjustment | Eleven Point Five Percent First Lien Senior Secured Notes | Original Issuance Discount                      
Reorganization, Chapter 11 [Line Items]                      
Debt Issuance Costs, Gross 13.0   13.0 13.0              
Reorganization, Chapter 11, Plan Effect Adjustment | Eleven Point Five Percent First Lien Senior Secured Notes | Deferred Debt Issuance Costs                      
Reorganization, Chapter 11 [Line Items]                      
Debt Issuance Costs, Gross 9.7   9.7 9.7              
Reorganization, Chapter 11, Plan Effect Adjustment | Debt                      
Reorganization, Chapter 11 [Line Items]                      
Reorganization Plan Adjustment (492.1)   (492.1) (492.1)              
Reorganization, Chapter11, Post Adjustment, Successor                      
Reorganization, Chapter 11 [Line Items]                      
Cash and cash equivalents 297.9   297.9 297.9              
Medicaid lawsuit liability 16.5   16.5 16.5              
Acthar Gel-Related Settlement, Non-current 63.2   63.2 63.2              
Opioid-Related Litigation Settlement liability, Current 200.0   200.0 200.0              
Opioid-Related Litigation Settlement liability 304.3   304.3 304.3              
Liabilities subject to compromise 0.0   0.0 0.0              
Stockholders' Equity Attributable to Parent $ 2,203.6   $ 2,203.6 $ 2,203.6